Polypeptide hormones, growth factors and a variety of other naturally occurring ligands can be labelled with 125I; the biologically active labelled material binds specifically to a component of the cell or a subcellular constituent. On the basis of specificity for the ligand the binding site has been called a receptor. For the polypeptide hormones it was inferred, from early studies, that the ligand bound to the receptor was exposed to the external environment of the cell, since it could be perturbed by enzymes and antibodies [1, 2] .
The chemically well characterized hormone interacts with the poorly characterized receptor, an integral protein of the plasma membrane, in a saturable fashion to form a hormone-receptor complex. This complex represents the first step in the action of the hormone. Using equilibrium analytical methods the state of the receptor in terms of affinity and number of binding sites has been estimated in many conditions in both experimental animals and human subjects. It is important to emphasize that these studies, for the most part, have been carried out at low temperatures where equilibrium conditions are most closely simulated. At higher more physiological temperatures it has become clear that the hormone receptor interaction is more complex and cannot be described as a simple bimolecular reversible reaction. Furthermore, there are several diverse functions of the hormone-receptor complex: (a) both membrane and intracellular biological activities are linked in some way to the hormone-receptor complex [1, 3] ; (b) degradation of the ligand is linked to the binding of the ligand [4] ; and (c) ligand-induced regulation of 1 Much of this work was carried out while P. G. was a Visiting Professor, Institute of Histology and Embryology, University of Geneva the receptor is linked to the initial binding process [5] [6] [7] . In this review we will explore how direct visual probes of the hormone-receptor interaction have extended our concepts of: (a) the nature of the cell surface binding; (b) the subsequent fate of the ligand; and (c) the possible relevance of this process to hormone action, degradation and receptor regulation. Finally, we wilt emphasize that polypeptide hormones and growth factors are involved in a similar qualitative process to other unrelated ligands that bind to specific cell surface receptors ( Table 1) .
The Hormone at the Cell Surface
When 125I-insulin at physiological concentration is incubated with freshly isolated rat hepatocytes at 20 ~ for 5 minutes and the cell pellet prepared for autoradiography, the labelled material can be both qualitatively and quantitatively localized to the plasma membrane of the hepatocyte (Figs. 1 and 2) [9, 33] .
Earlier experiments demonstrated the localization of ferritin-insulin complexes to the membrane of the fat cell in thin section [34, 35] and to the true surface of hepatocyte membranes in freeze-etched preparations [36] . Ferritin cores appeared singly or in small groups and it was reported that in fat cells the ferritin groups were present in cells prefixed prior to incubation suggesting that these groups were naturally occurring [35] . More recently, using an elegant new method of video intensification microscopy, it was shown that insulin and epidermal growth factor conjugated to fluorescent lactalbumin bind diffusely to mouse fibroblasts at 4 ~ but at higher temperatures the ligand is mobile and forms clusters [16] . Since insulin behaved in a similar fashion to a-2 macroglobulin, it was suggested that insulin, like a-2 macroglobulin, is preferentially clustered in "coated pits" on the cell surface [30] .
Anderson et al. have demonstrated that ferritinconjugated low density lipoprotein (ferritin-LDL) is preferentially localized in "coated pits" in human fibroblasts and that this is true in cells fixed to prevent mobility prior to incubation [26] . By contrast in a mutant fibroblast cell line that binds but does not internalize the LDL, the ligand is not localized in "coated pits" [27, 28] . The coated segment of the membrane is made up primarily of the protein clathrin as well as several other minor components [37, 38] .
Studies in cultured human lymphocytes have also demonstrated that 125I-insulin and 125I-anti-insulin receptor antibody are redistributed in the plane of the membrane as a function of temperature. The hormone or specific immunoglobulin binds initially at low temperatures in a diffuse fashion around the plasma membrane but at higher temperatures the ligand redistributes toward the Golgi pole of the cell in a form analogous to capping [39, 40] .
While the "coated pit" is an important structure for polypeptide hormones, growth factors and LDL in fibroblasts, preferential initial localization of the ligand to these structures is not found for 125I-insulin in rodent hepatocytes [11] or cultured human lymphocytes [39] nor for ferritin-LDL in circulating lymphocytes [29] .
Several important generalizations can be drawn from these studies: (a) Insulin receptors may exist in naturally occurring groups on the cell surface but this conclusion depends totally on the monomeric nature of ferritin-insulin [35] . Either the natural groups or isolated receptors can be redistributed in the plane of the membrane. (b) Receptors may be localized in specialized structures on the cell surface such as the "coated pits" or they may localize randomly and cluster in these specialized structures. (c) While the coated pit or invagination is an excellent model of a type of specificity that is undoubtly important in fibroblasts, has not yet been demonstrated to be responsible for the intemalization of the ligand in other cell types. It is dear, however, that these studies are at an early stage of development and additional data will be required to define more precisely the role of the "coated pit".
It seems clear that the hormone or other ligand receptor can exist in a specific domain or microenvironment on the cell surface; this microenv/ronment, therefore, provides a mechanism whereby specific ligands may regulate the concentration of their unique receptor. The process by which a macromolecule enters an ,x intact cell is endocytosis or more specifically pinocy-:; a: tosis [41] . In the case of a ligand that binds to the cell o z and is concentrated on the surface the process is known as adsorptive pinocytosis [41] . Macromolecules that do not bind to the cell surface may be taken up by fluid-phase pinocytosis in proportion to their concentration in the incubation media but this For details see [33] process is much less efficient than adsorptive pinocytosis. Pinocytosis involves the invagination of a segment of the membrane (size of the invagination depends on the cell type). The invaginated membrane then fuses and pinches off the plasma membrane in an energy consuming step or steps to form a small pinocytotic vesicle. The ligand is, therefore, internalized in a membrane-bounded compartment. Qualitative images of these events have been demonstrated for ferritin-EGF in A-431 cells [21] and for ferritin-LDL in human fibroblasts [26] .
The rate controlling steps for the internalization process are unclear. We have found that the amount of the ligand internalized is proportional to the concentration of the ligand bound to the plasma membrane and suggested that binding per se may be the rate controlling step of internalization (Fig. 4) [33] .
While many different ligands that bind to the cell surface are internalized by cells, the rate and magnitude of the internalization process is different for different ligands in different cell types. For instance, in the cultured human lymphocyte at steady-state we find that only about 15 to 20% of 125I-insulin is inter- Fig. 5 . Thin section of isolated hepatocyte with developed autoradiographic grains. "Ly" refers to lysosome-like structures where grains have been shown to preferentially localize. For details see [11, 12] nalized [2] while in the hepatocyte under similar conditions 40-50% of the ligand is internalized [9, 33] . On the other hand, human growth hormone in the cultured human lymphocyte is internalized in a similar fashion to insulin in the hepatocyte [22] . Thus, neither the specific ligand nor the cell determines the rate or magnitude of the internalization process.
Intraeellular Localization of the Hormone
If insulin is internalized by the process of adsorptive pinocytosis, the ligand enters the intracellular compartment by way of a pinocytotic vesicle. As previously mentioned, in some instances these vesicles are coated, but in other cases as for insulin internalization in hepatocytes, we have not found localization to coated invaginations on the cell surface [11] . Typically endocytic vesicles fuse with lysosomes [41] and we have found that 125I-insulin is preferentially localized in lysosomes in isolated hepatocytes [10, 11] and in perfused rat liver (Fig. 5) [14] . We have also found preferential localization of other inter- . Analysis of hepatocyte associated radioactivity from 0 to 60 rain of incubation at 37 ~ C. The cell associated radioactivity was extracted and filtered on Sephadex G-50. Peak II is the elution profile of intact 125-I-insulin, peak I is from the void volume (i. e. high molecular weight) and peak III elutes past the 125I-marker in the region of iodotyrosyle peptides (i. e. low molecular weight). Note the various fractions are relatively constant as a function of incubation time. For details see [11] nalized ligands to lysosomes. These include anti-insulin receptor antibody [17] and human growth hormone in cultured human lymphocytes [22] , epidermal growth factor in human fibroblasts [19] and rat hepatocytes [42] , and glucagon in rat hepatocytes [23] . In addition we have compared the EM autoradiographic method with two other systems that have used ferritin-coupled ligands. Ferritin-LDL is localized in lysosomes of human fibroblasts [26] and ferritin-EGF is localized in lysosomes of A-431 cells (Table 1) . We have made essentially identical observations using 125I-labelled ligands in each of these cell types [28] .
In the perfused rat liver, Bergeron et al. have found that labelled insulin is primarily localized in lysosome-like structures but also finds localization to defined Golgi elements [13] . While we find labelled insulin and other ligands localized in the Golgi region of the cell which is rich in lysosomes [12] , we cannot preferentially localize insulin or other ligands to morphologically identifiable Golgi structures.
By contrast to these studies, Goldfine et al. have found 125I-insulin preferentially localized to endoplasmic reticulum and nuclear membrane in the cultured human lymphocyte [15] . The explanation for these different experimental findings is unclear.
We interpret our data to indicate that the ligand binds to the cell surface, is internalized in membranebounded vesicles and these vesicles fuse with lysosomes. Lysosomes are typically concentrated in the Golgi region of the cell. Thus, under continuous incubation conditions the ligand moves from the cell surface, through a vesicular compartment to lysosomes. Lysosomes are identified both on the basis of their morphologic characteristics and by cytochemical techniques (Fig. 5) .
lntracellular Receptors
Receptors for insulin have been reported on Golgi structures [43] [44] [45] , nuclei [46, 47] and endoplasmic reticulum [3] . The binding sites on these structures are similar to the plasma membrane receptor with respect to specificity for insulin and insulin analogues. The nuclear binding site is different in several respects from plasma membrane receptors in that it has a different pH optimum, shows no accelerated dissociation of labelled insulin in the presence of an excess of unlabelled insulin and binding to this site is not inhibited by anti-insulin receptor antibody [48, 49] .
Golgi receptors have been characterized in detail both biochemically or morphologically and have very similar properties to plasma membrane receptors Ph. Gorden et al.: Internalization of Polypeptide Hormones [44, 45] . These receptors are probably located on the inner membrane of the Golgi cisternae and binding to these structures is enhanced by manoeuvres that disrupt membranes such as freezing and thawing [44] . This strongly suggests that these sites may represent the biosynthetic precursor of the plasma membrane receptor. Evidence for this concept has been presented for the acetylcholine receptor [50] . This could also be true for the receptor in endoplasmic reticulum. The function of the nuclear receptors is less clear, but it has been suggested that it may mediate some of the long-term effects of insulin [46, 47] .
In our studies, we have been unable to show that the hormone that initially binds to the plasma membrane subsequently becomes localized in defined Golgi elements, endoplasmic reticulum or nuclei.
Implications for Hormone Action
The binding of the hormone to its receptor is necessary but not sufficient for the full expression of hormone action. For some polypeptide hormones such as glucagon all the required components for the expression of the hormone's action appear to be contained in the plasma membrane including the receptor, adenylate cyclase and the nucleotide regulatory component. Glucagon is a classic hormone with its intracellular effects presumably mediated by a second messenger. Insulin, growth hormone and the various growth factors and somatomedins also regulate many intracellular events and it has been widely felt that there must be a second messenger system for these agents as well. While enthusiasm has waxed and waned there has been no clear second messenger identified for these hormones and it is reasonable to question whether or not internalization of these ligands is a component of their biologic action.
Before considering the polypeptide hormones, it is useful to review the components of the best studied biological model of receptor binding, internalization and intracellular regulation. There are three important components necessary for LDL to regulate cholesterol metabolism in fibroblasts [51, 52] . First, there must be a cell surface receptor to recognize and bind LDL; second, the receptor must be localized in coated pits to allow the LDL receptor complex to be internalized; and third, the vesicles internalizing the LDL must fuse with lysosomes to allow lysosomal enzymes to release free cholesterol from the protein complex.
We have shown that all of these events occur for insulin, growth hormones and epidermal growth factor, but to what extent are they required for hormone action? While it is possible to speculate that the entire insulin molecule is necessary for receptor binding and that the molecule is subsequently internalized to release an active fragment [53, 54] , or that the internalized receptor may mediate some intracellular response [55] , there is little direct evidence to support these speculations. In fact, in limited studies it appears that when internalization is impaired [56] , or lysosomal enzymes inhibited [57, 58] there is no inhibition of hormone action. In addition, hormones with classic second messengers are internalized in a similar fashion to insulin and related ligands [23] [24] [25] . Thus, at the present time, there is no definitive experiment to prove that internalization is not a necessary step in hormone action, but there is little positive evidence for this concept.
An immunoglobulin has been isolated from the plasma of a group of severely insulin resistant patients [59] . This immunoglobulin behaves like an antibody to the insulin receptor; it competes with insulin for receptor binding and it can produce all of the biologic effects of insulin [60] [61] [62] . Recently it has been shown that the univalent Fab component is an insulin antagonist but can be converted to an agonist by the addition of anti-Fab antibody [63] . This suggests that cross-linking of the antibody is in some way involved in its agonistic properties. Small concentrations of anti-insulin antibody will also increase to a small extent the effect of insulin bound to adipocytes while large concentrations of antibody are known to inhibit. These studies raise the possibility that crosslinking of either the ligand, their receptors or some other component of the membrane may be one of the post-binding steps involved in hormone action. It is interesting that labelled anti-receptor antibody displays all of the same morphologic events as does insulin; these include binding to the plasma membrane, redistribution in the plane of the membrane, internalization and lysosomal association. Thus, some form of cross-linking may be involved in hormone action and in the internalization process per se but whether these phenomenon are related is unknown at present.
Implications for Hormone Degradation
Using a perfused liver system Mortimer and Teitze showed 20 years ago that at low temperatures labelled insulin was "trapped" by the liver but not degraded, while at higher temperatures the hormone was "trapped" and following a brief delay the hormone was degraded [64] . Terris and Steiner confirmed these studies in the perfused rat liver [65] and extended the studies to the isolated hepatocyte where they demonstrated that insulin degradation by the [11] hepatocyte had all the characteristics of a receptor linked process [4] . On the other hand, it has also been shown in liver membranes and in isolated hepatocytes that a soluble degradative system exists which does not require binding nor even the continued presence of the cell [66, 67] . This form of degradation can be inhibited by bacitracin and other protease inhibitors and if present in the system must be neutralized before receptor linked degradation can be studied (Figs. 6 and 7) [11] .
As previously discussed, following binding of insulin to isolated hepatocytes, the ligand is internalized as a function of time and temperature. The ligand is internalized in a membrane-bounded compartment and these pinocytotic vesicles subsequently fuse with lysosomes [11] . Since these morphologic observations, and the studies of Carpenter and Cohen showing that EGF degradation was inhibited by lysosomal stabilizing agents [68] , many investigators have shown that agents such as chlorquine and ammonium chloride inhibit cell related insulin degradation but not soluble proteases previously discussed [69] [70] [71] [72] [73] [74] .
Thus, it seems reasonable that the internalization pathway for insulin in hepatocytes is primarily a degradative pathway involved in removing the ligand If receptor-linked degradation is a major physiological process then it appears to be mediated by receptor-linked internalization. This would mean that the degradation of insulin and other polypeptide hormones and growth factors is primarily a lysosomal process. Since most in vitro studies of insulin degradation have been carried out in homogenates at physiological pH, a lysosomal process would not have been detected; very few studies have considered this point [75, 76] . Thus it remains unclear to what extent and by what mechanisms membrane-associated proteases or transhydrogenase are involved in the physiological degradation of insulin.
It was first pointed out by Kahn and Baird that at 37 ~ insulin becomes relatively less dissociable from, adipocytes as a function of the length of incubation time and the labelled material that dissociates from the cell progressively appears as degradation products [77] . We have confirmed these findings in isolated hepatocytes and have further shown that dissociation and degradation can be delayed by the lysosomal stabilizing agent ammonium chloride [69] . This is consistent with the idea that the labelled ligand once internalized by the cell can not be released until it is degraded.
Implications for Receptor Regulation
It was first shown in severely insulin resistant hyperinsulinaemic obese mice that the concentration of insulin receptors on the cell accessible for binding was reduced compared to normal controls [78, 79] . .~'~r--Receptor These studies were extended to obese, hyperinsulinaemic man and similarly reduced receptor concentrations were found [80] [81] [82] [83] [84] . It was shown in both mice and men that the receptor concentration was inversely proportional to the ambient insulin concentration [81, 85] . These studies were extended to in vitro systems where it was shown that the insulin receptor concentration of the cultured human lymphocyte was reduced as a function of time, temperature, and insulin concentration in the media and that this reduction was specific for the insulin receptor [5] . Again, receptor binding is necessary but not sufficient for the expression of this effect. Growth hormone can mediate the loss of its unique receptor but has no effect on the insulin receptor [6] . Hormoneinduced receptor loss or "down regulation" represents a new steady-state where binding is reduced up to 20% of maximal. This process has now been demonstrated for many hormones and growth factors.
If the hormone is internalized by adsorptive pinocytosis then the membrane segment containing the receptor should be internalized with the ligand. This has led us to suggest that receptor-linked hormone degradation and receptor-linked hormoneinduced receptor loss are coupled processes [7, 9] .
If the down regulation process is a new steadystate of reduced receptor concentration and if this process is mediated by internalization then net receptor concentration on the cell surface will represent a dynamic equilibrium between the rate of membrane internalization, receptor degradation, membrane recycling and the rate receptors are synthesized, transported, and inserted into the membrane. Quantitative data on these processes is essentially nonexistent and it is, therefore, not surprising that if hormone degradation and receptor loss are coupled, they do not occur in concert. Hormone degradation is rapid, usually occurring in minutes, whereas, down regulation of receptors usually requires hours.
Several factors suggest that hormone-induced receptor loss is mediated by internalization: (a) membrane microheterogenity, where classes of receptors occur in specific domains or move in the plane of the membrane by clustering and patching, could explain the exquisite specificity of the process; (b) the concentration of ligand necessary to induce receptor loss is inversely proportional to the magnitude and rate of internalization of the ligand (Table  2) ; and (c) the conditions that induce receptor loss are associated with an increase in the pinocytotic rate of the cell [7, 86] .
It seems reasonable to conclude that internalization may be the major mechanism by which cell surface receptors are regulated, but it is clear that this is a complex process with many potential control points.
While it is known that receptor affinity can be experimentally modified, for instance, by starvation, decrease in pH or by a variety of physical agents the mechanism of these changes is unclear. Available data suggest that receptors may exist as a single affinity class, as multiple affinity classes [84] or change as a function of occupancy (negative cooperativity) [88] . At present there is no information to implicate the internalization process in the regulation of receptor affinity. Negative cooperativity is seen most prominantly at low temperatures of dissociation but is not significantly influenced by the temperature of association of the ligand to the cell. By contrast the temperature of association strongly influences the rate and magnitude of internalization.
Conclusions and Speculations
In this review we have illustrated the interaction of 125I-insulin with isolated hepatocytes, since the liver is the major target of all the actions of insulin. We have emphasized throughout that the events involved in the interaction of insulin with hepatocytes is qualitatively similar to the events involved in the interaction of many other polypeptide hormones, growth factors, lipoproteins and other ligands with cells. These general mechanisms include: (a) binding of the ligand to cell surface receptors, in some instances to specialized domains of the membrane such as coated pits; (b) redistribution of the ligand in the plane of the membrane providing a mechanism for the segregation of a given class of receptors; (c) internaliation of the ligand by adsorptive pinocytosis into a membrane-bounded compartment; and (d) transfer of the ligand and probably its receptor to lysosomes where the ligand is degraded and the receptor either degraded or recycled back to the membrane (Fig. 8) .
The binding of the Hormone (H) to Receptor (R) is a requirement for hormone action. Thus, the magnitude of HR at the cell surface is a major determinant of the magnitude of response. The concentration of H at any given time at the cell surface is a function of the concentration of H bound and H internalized. Similarly the concentration of R is critically determined by the amount of membrane internalized; internalization, therefore, provides a simple mechanism that couples hormone degradation with receptor regulation. If this is true, from a clinical view point, we can begin to think of mechanisms to maintain HR on the cell surface.
Finally, if one considers these general mechanisms common to many ligands and many cells, it is not surprising that peripheral blood cells and other non-target cells mirror the status of the insulin receptor on major target tissues.
